Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Return on Equity (2018 - 2025)

Historic Return on Equity for Dianthus Therapeutics (DNTH) over the last 7 years, with Q3 2025 value amounting to 0.3%.

  • Dianthus Therapeutics' Return on Equity fell 1000.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.32% for FY2024, which is 3700.0% up from last year.
  • According to the latest figures from Q3 2025, Dianthus Therapeutics' Return on Equity is 0.3%, which was down 1000.0% from 0.36% recorded in Q2 2025.
  • Dianthus Therapeutics' Return on Equity's 5-year high stood at 0.64% during Q2 2023, with a 5-year trough of 0.73% in Q3 2023.
  • Over the past 4 years, Dianthus Therapeutics' median Return on Equity value was 0.25% (recorded in 2023), while the average stood at 0.15%.
  • As far as peak fluctuations go, Dianthus Therapeutics' Return on Equity surged by 9000bps in 2023, and later crashed by -8000bps in 2024.
  • Quarter analysis of 4 years shows Dianthus Therapeutics' Return on Equity stood at 0.45% in 2022, then plummeted by -155bps to 0.25% in 2023, then rose by 2bps to 0.24% in 2024, then fell by -21bps to 0.3% in 2025.
  • Its Return on Equity was 0.3% in Q3 2025, compared to 0.36% in Q2 2025 and 0.29% in Q1 2025.